- Home
- Publications
- Publication Search
- Publication Details
Title
Immunological and classical subtypes of oral premalignant lesions
Authors
Keywords
-
Journal
OncoImmunology
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2018-09-22
DOI
10.1080/2162402x.2018.1496880
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions
- (2017) Takahiro Yagyuu et al. ORAL ONCOLOGY
- Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma
- (2016) Nghia Nguyen et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Lymph Node Count From Neck Dissection Predicts Mortality in Head and Neck Cancer
- (2016) Vasu Divi et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
- (2016) Laura Q.M. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
- (2016) Tanguy Y Seiwert et al. LANCET ONCOLOGY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis
- (2016) Yannan Fan et al. NUCLEIC ACIDS RESEARCH
- Leveraging premalignant biology for immune-based cancer prevention
- (2016) Avrum Spira et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer
- (2016) Jean-Philippe Foy et al. Oncotarget
- Oral Cancer Chemoprevention—The End of EPOC, the Beginning of an Epoch of Molecular Selection
- (2016) Julie E. Bauman et al. JAMA Oncology
- Erlotinib and the Risk of Oral Cancer
- (2016) William N. William et al. JAMA Oncology
- A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
- (2015) M. P. Mak et al. CLINICAL CANCER RESEARCH
- Malignant transformation of oral leukoplakia: a systematic review of observational studies
- (2015) S. Warnakulasuriya et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Orchestrating high-throughput genomic analysis with Bioconductor
- (2015) Wolfgang Huber et al. NATURE METHODS
- Immune-mediated antitumor effect by type 2 diabetes drug, metformin
- (2015) Shingo Eikawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program
- (2015) Shicheng Su et al. Nature Communications
- Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data
- (2015) Loris De Cecco et al. Oncotarget
- Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes
- (2014) M. K. Keck et al. CLINICAL CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of miR-142-3p on the M2 Macrophage and Therapeutic Efficacy Against Murine Glioblastoma
- (2014) Shuo Xu et al. JNCI-Journal of the National Cancer Institute
- ForceAtlas2, a Continuous Graph Layout Algorithm for Handy Network Visualization Designed for the Gephi Software
- (2014) Mathieu Jacomy et al. PLoS One
- Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
- (2013) P Balermpas et al. BRITISH JOURNAL OF CANCER
- Bowman Birk Inhibitor Concentrate and Oral Leukoplakia: A Randomized Phase IIb Trial
- (2013) W. B. Armstrong et al. Cancer Prevention Research
- MicroRNA Regulation of T-Lymphocyte Immunity: Modulation of Molecular Networks Responsible for T-Cell Activation, Differentiation, and Development
- (2013) Katie Podshivalova et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Is there any benefit in surgery for potentially malignant disorders of the oral cavity?
- (2013) I. Balasundaram et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes
- (2013) Vonn Walter et al. PLoS One
- Loss of Heterozygosity (LOH) Profiles--Validated Risk Predictors for Progression to Oral Cancer
- (2012) L. Zhang et al. Cancer Prevention Research
- Gene Expression Profiling Predicts the Development of Oral Cancer
- (2011) P. Saintigny et al. Cancer Prevention Research
- MicroRNAs regulatory networks in myeloid lineage development and differentiation: regulators of the regulators
- (2011) Mohamed El Gazzar et al. IMMUNOLOGY AND CELL BIOLOGY
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
- (2010) Matthew D. Wilkerson et al. BIOINFORMATICS
- Inhibition of EGFR-STAT3 Signaling with Erlotinib Prevents Carcinogenesis in a Chemically-Induced Mouse Model of Oral Squamous Cell Carcinoma
- (2010) R. J. Leeman-Neill et al. Cancer Prevention Research
- Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral Cancer
- (2010) M. Taoudi Benchekroun et al. Cancer Prevention Research
- Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types
- (2010) M. D. Wilkerson et al. CLINICAL CANCER RESEARCH
- A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis
- (2010) Humam Kadara et al. CLINICAL CANCER RESEARCH
- Np63 Overexpression, Alone and in Combination with Other Biomarkers, Predicts the Development of Oral Cancer in Patients with Leukoplakia
- (2009) P. Saintigny et al. CLINICAL CANCER RESEARCH
- microRNAs and the immune response
- (2009) Eleni Tsitsiou et al. CURRENT OPINION IN PHARMACOLOGY
- Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma
- (2009) Nilva K. Cervigne et al. HUMAN MOLECULAR GENETICS
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions
- (2008) V. A. Papadimitrakopoulou et al. CLINICAL CANCER RESEARCH
- Randomized Trial of 13-cis Retinoic Acid Compared With Retinyl Palmitate With or Without Beta-Carotene in Oral Premalignancy
- (2008) Vassiliki A. Papadimitrakopoulou et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started